References
Abdel-Fatah TM, Powe DG, Hodi Z, et al. (2007) High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma. Am J Surg Pathol 31: 417–426
Ali-Fehmi R, Carolin K, Wallis T, Visscher DW (2003) Clinicopathologic analysis of breast lesions associated with multiple papillomas. Hum Pathol 34: 234–239
Allemand H, Seradour B, Weill A, Ricordeau P (2008) Decline in breast cancer incidence in 2005 and 2006 in France: a paradoxical trend. Bull Cancer 95: 11–15
Alm El-Din MA, Hughes KS, Finkelstein DM, et al. (2009) Breast cancer after treatment of Hodgkin’s lymphoma: risk factors that really matter. Int J Radiat Oncol Biol Phys 73(1): 69–74
Anderson BO, Calhoun KE, Rosen EL (2006) Evolving concepts in the management of lobular neoplasia. J Natl Compr Canc Netw 4: 511–522
Aroner SA, Collins LC, Schnitt SJ, et al. (2010) Columnar cell lesions and subsequent breast cancer risk: a nested case-control study. Breast Cancer Res 12: R61
Arpino G, Allred DC, Mohsin SK, et al. (2004) Lobular neoplasia on core-needle biopsy — clinical significance. Cancer 101: 242–250
Arpino G, Laucirica R, Elledge RM (2005) Premalignant and in situ breast disease: biology and clinical implications. Ann Intern Med 143: 446–457
Barlow WE (2006) Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst 98(17): 1204–1214
Barrett-Connor E, Mosca L, Collins P, et al. (2006) Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med 355: 125–137
Bauer VP, Ditkoff BA, Schnabel F, et al. (2003) The management of lobular neoplasia identified on percutaneous core breast biopsy. Breast J 9: 4–9
Berg WA, Blume JD, Cormack JB, et al. (2008) ACRIN 6666 Investigators. Combined screening withultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA 299(18): 2151–2163
Bijker N, Peterse JL, Duchateau L, et al. (2001) Risk factors for recurrence and metastasis after breastconserving therapy for ductal carcinoma in situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 19: 2263–2271
Bijker N, Rutgers EJ, Peterse JL, et al. (2001) Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS. Eur J Surg Oncol 27: 135–40
Bratthauer GL, Tavassoli FA (2002) Lobular intraepithelial neoplasia: previously unexplored aspects assessed in 775 cases and their clinical implications. Virchows Arch 440: 134–138
Bratthauer GL, Tavassoli FA (2004) Assessment of lesions coexisting with various grades of ductal intraepithelial neoplasia of the breast. Virchows Arch 444: 340–344
Brem RF, Behrndt VS, Sanow L, Gatewood OM (1999) Atypical ductal hyperplasia: histologic underestimation of carcinoma in tissue harvested from impalpable breast lesions using 11-gauge stereotactically guided directional vacuum-assisted biopsy. AJR Am J Roentgenol 172: 1405–1407
Brogi E, Oyama T, Koerner FC (2001) Atypical cystic lobules in patients with lobular neoplasia. Int J Surg Pathol 9: 201–206
Brogi E, Tan LK(2002) Findings at excisional biopsy (EBX) performed after identification of columnar cell change (CCC) of ductal epithelium in breast core biopsy (CBX). Mod Pathol 15: 29A–30A
Bur ME, Zimarowski MJ, Schnitt SJ, et al. (1992) Estrogen receptor immunohistochemistry in carcinoma in situ of the breast. Cancer 69: 1174–1181
Cangiarella J, Guth A, Axelrod D, et al. (2008) Is surgical excision necessary for the management of atypical lobular hyperplasia and lobular carcinoma in situ diagnosed on core needle biopsy? A report of 38 cases and review of the literature. Arch Pathol Lab Med 132: 979–983
Carney PA, Miglioretti DL, Yankaskas BC, et al. (2003) Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 138(3): 168–175 [Erratum in: Ann Intern Med 2003 May 6; 138(9): 771]
Chuba PJ, Hamre MR, Yap J, et al. (2005) Bilateral risk for subsequent breast cancer after lobular carcinoma in situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol 23: 5534–5541
Colditz GA, Rosner BA, Speizer FE (1996) Risk factors for breast cancer according to family history of breast cancer. For the Nurses’ Health Study Research Group. J Natl Cancer Inst 88: 365–371
Colin C, Prince V, Valette PJ (2010) Can mammographic assessments lead to consider density as a risk factor for breast cancer? Eur J Radiology 4465
Collins LC, Achacoso NA, Nekhlyudov L, et al. (2007) Clinical and pathologi features of ductal carcinoma in situ associated with presence of flat epithelial atypia: an analysis of 543 patients. Mod Pathol 20: 1149–1155
Collins LC, Baer HJ, Tamimi RM, et al. (2007) Magnitude and laterality of breast cancer risk according to histology type of atypical hyperplasia: results from the Nurses’ Health Study. Cancer 109: 180–187
CRC (1988) Cyclophosphamide and tamoxifen as adjuvant therapies in the management of breast cancer. CRC Adjuvant Breast Trial Working Party. Br J Cancer 57: 604–607
Cummings SR, Eckert S, Krueger KA, et al. (1999) The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple outcomes of raloxifene evaluation. JAMA 281: 2189–2197
Cutuli B, Cottu PH, Guastalla JP, et al. (2006) A French national survey on infiltrating breast cancer: analysis of clinico-pathological features and treatment modalities in 1,159 patients. Breast Cancer Res Treat 95: 55–64
Cuzick J, Forbes J, Edwards R, et al. (2002) First results from the International Breast Cancer Intervention Study (IBIS-I): a randomized prevention trial. Lancet 360: 817–824
Cuzick J, Powles T, Veronesi U, et al. (2003) Overview of the main outcomes in breast-cancer prevention trials. Lancet 361: 296–300
Dabbs DJ, Carter G, Fudge M, et al. (2006) Molecular alterations in columnar cell lesions of the breast. Mod Pathol 19: 344–349
Darling ML, Smith DN, Lester SC, et al. (2000) Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: results of surgical excision. AJR Am J Roentgenol 175: 1341–1346
David N, Labbe-Devilliers C, Moreau D, et al. (2006) Lésions de métaplasie cylindrique atypique (MCA) diagnostiquées par macrobiopsies assistées par aspiration: opportunité d’une exérèse chirurgicale ? J Radiol 87: 1671–1677
De Mascarel I, Mac Grogan G (2007) Prise en charge des atypies épithéliales du sein. Ann Pathol 27: 182–194
De Mascarel I, Mac Grogan G, Mathoulin-Pelissier S, et al. (2007) Epithelial atypia in biopsies performed for microcalcifications. Practical considerations about 2,833 serially sectioned surgical biopsies with a long follow-up. Virchows Arch 451: 1–10
Degnim AC, Visscher DW, Berman HK, et al. (2007) Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J Clin Oncol 25: 2671–2677
Doren E, Hulvat M, Norton J, et al. (2008) Predicting cancer on excision of atypical ductal hyperplasia. Am J Surg 195: 358–361 [361–2 discussion]
Douglas-Jones AG, Denson JL, Cox AC, et al. (2006) Radial scar lesions of the breast diagnosed by needle core biopsy: analysis of cases containing occult malignancy. J Clin Pathol 60(3): 295–298 [Epub 2006 May 26]
Dupont WD, Parl FF, Hartmann WH, et al. (1993) Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 71: 1258–1265
Eisinger F, Bressac B, Castaigne D, et al. (2004) Identification and management of hereditary predisposition to cancer of the breast and the ovary (update 2004). Bull Cancer 91(3): 219–237 [Review French]
Elston CW, Sloane JP, Amendoeira I, et al. (2000) Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast. European Commission Working Group on Breast Screening Pathology. Eur J Cancer 36: 1769–1772
Ely KA, Carter BA, Jensen RA, et al. (2001) Core biopsy of the breast with atypical ductal hyperplasia: a probabilistic approach to reporting. Am J Surg Pathol 25: 1017–1021
Eusebi V, Mignani S, Koerner F, Oyama T (2001) Well differentiated clinging carcinoma and atypical ductal hyperplasia are synonymous. Breast Cancer 8: 283–284
Fadare O, Dadmanesh F, Alvarado-Cabrero I, et al. (2006) Lobular intraepithelial neoplasia (lobular carcinoma in situ) with comedo-type necrosis: a clinicopathologic study of 18 cases. Am J Surg Pathol 30: 1445–1453
Farshid G, Rush G (2004) Assessment of 142 stellate lesions with imaging features suggestive of radial scar discovered during population-based screening for breast cancer. Am J Surg Pathol 28: 1626–1631
Fasching PA, Bani MR, Nestle-Krämling C, et al. (2007) Evaluation of mathematical models for breast cancer risk assessment in routine clinical use. Eur J Cancer Prev 16(3): 216–224
Fasih T, Jain M, Shrimankar J, et al. (2005) All radial scars/complex sclerosing lesions seen on breast screening mammograms should be excised. Eur J Surg Oncol 31: 1125–1128
Fisher B, Costantino J, Redmond C, et al. (1989) A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med 320: 479–484
Fisher B, Costantino JP, Wickerham DL, et al. (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90: 1371–1388
Fisher B, Costantino JP, Wickerham DL, et al. (2005) Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 97: 1652–1662
Fitzgibbons PL, Henson DE, Hutter RV (1998) Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med 122: 1053–1055
Foregeard C, Benchaib M, Guerin N, et al. (2008) Is surgical biopsy mandatory in case of atypical ductal hyperplasia on 11-gauge core needle biopsy? A retrospective study of 300 patients. Am J Surg 196(3): 339–345
Fraser JL, Raza S, Chorny K, et al. (1998) Columnar alteration with prominent apical snouts and secretions: a spectrum of changes frequently present in breast biopsies performed for microcalcifications. Am J Surg Pathol 22: 1521–1527
Friedenreich C, Bryant H, Alexander F, et al. (2000) Risk factors for benign proliferative breast disease. Int J Epidemiol 29: 637–644
Gail MH, Brinton LA, Byar DP, et al. (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81: 1879–1886
Georgian-Smith D, Lawton TJ (2001) Calcifications of lobular carcinoma in situ of the breast: radiologic-pathologic correlation. AJR Am J Roentgenol 176: 1255–1259
Ghofrani M, Tapia B, Tavassoli FA (2006) Discrepancies in the diagnosis of intraductal proliferative lesions of the breast and its management implications: results of a multinational survey. Virchows Arch 449: 609–616
Greene T, Tartter PI, Smith SR, Estabrook A (2006) The significance of surgical margins for patients with atypical ductal hyperplasia. Am J Surg 192: 499–501
Guerra-Wallace MM, Christensen WN, White RL Jr (2004) A restrospective study of columnar alteration with prominent apical snouts and secretions and the association with cancer. Am J Surg 188: 395–398
Haagensen CD, Lane N, Lattes R, Bodian C (1978) Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 42: 737–769
Hartmann LC, Sellers TA, Frost MH, et al. (2005) Benign breast disease and the risk of breast cancer. N Engl J Med 353: 229–237
Hede K (2004) Rexinoids may be ready for prime time in prevention, but challenges remain. J Natl Cancer Inst 96: 1807–1808
Hwang H, Barke LD, Mendelson EB, Susnik B (2008) Atypical lobular hyperplasia and classic lobular carcinoma in situ in core biopsy specimens: routine excision is not necessary. Mod Pathol 21(10): 1208–1216
Jacobi CE, de Bock GH, Siegerink B, van Asperen CJ (2009) Differences and similarities in breast cancer risk assessment models in clinical practice: which model to choose? Breast Cancer Res Treat 115(2): 381–390 [Epub 2008 May 30]
Jacobs TW, Byrne C, Colditz G, et al. (1999) Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N Engl J Med 340(6): 430–436
Jacobs TW, Connolly JL, Schnitt SJ (2002) Nonmalignant lesions in breast core needle biopsies: to excise or not to excise? Am J Surg Pathol 26: 1095–1110
Jacobs TW, Schnitt SJ, Tan X, Brown LF (2002) Radial scars of the breast and breast carcinomas have similar alterations in expression of factors involved in vascular stroma formation. Hum Pathol 33: 29–38
Jordan VC, Lababidi MK, Langan-Fahey S (1991) Suppression of mouse mammary tumorigenesis by long-term tamoxifen therapy. J Natl Cancer Inst 83: 492–496
Koerner FC, Oyama T, Maluf H (2001) Morphological observations regarding the origins of atypical cystic lobules (low-grade clinging carcinoma of flat type). Virchows Arch 439: 523–530
Kriege M, Brekelmans CT, Boetes C, et al. (2004) Magnetic Resonance Imaging Screening Study Group. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351(5): 427–437
Kuhl CK, Schrading S, Leutner CC, et al. (2005) Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23: 8469–8476
Kunju LP, Kleer CG (2007) Significance of flat epithelial atypia on mammotome core needle biopsy: should it be excised? Hum Pathol 38: 35–41
Lakhani SR, Audretsch W, Cleton-Jensen AM, et al. (2006) The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)? Eur J Cancer 42: 2205–2211
Lavoue V, Graesslin O, Classe JM, et al. (2007) Management of lobular neoplasia diagnosed by core needle biopsy: study of 52 biopsies with follow-up surgical excision. Breast 16: 533–539
Leach MO, Boggis CR, Dixon AK, et al. (2005) Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365(9473): 1769–1778 [Erratum in: Lancet 2005 May 28–Jun 3; 365(9474): 1848]
Leconte I, Feger C, Galant C, et al. (2003) Mammography and subsequent whole-breast sonography of nonpalpable breast cancers: the importance of radiologic breast density. AJR Am J Roentgenol 180(6): 1675–1679
Lee CH, Dershaw DD, Kopans D, et al. (2010) Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol 7(1): 18–27
Lerwill MF (2006) The evolution of lobular neoplasia. Adv Anat Pathol 13: 157–165
Lerwill MF (2008) Flat epithelial atypia of the breast. Arch Pathol Lab Med 132: 615–621
Lewis JT, Hartmann LC, Vierkant RA, et al. (2006) An analysis of breast cancer risk in women with single, multiple, and atypical papilloma. Am J Surg Pathol 30: 665–672
Li CI, Malone KE, Saltzman BS, Daling JR (2006) Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001. Cancer 106: 2104–2112
Liberman L, Holland AE, Marjan D, et al. (2007) Underestimation of atypical ductal hyperplasia at MRI-guided 9-gauge vacuum-assisted breast biopsy. AJR Am J Roentgenol 188: 684–690
Liby K, Rendi M, Suh N, et al. (2006) The combination of the rexinoid, LG100268, and a selective estrogen receptor modulator, either arzoxifene or acolbifene, synergizes in the prevention and treatment of mammary tumors in an estrogen receptor-negative model of breast cancer. Clin Cancer Res 12: 5902–5909
Londero V, Zuiani C, Linda A, et al. (2008) Lobular neoplasia: core needle breast biopsy underestimation of malignancy in relation to radiologic and pathologic features. Breast 17(6): 623–630
Lopez-Medina A, Cintora E, Mugica B, et al. (2006) Radial scars diagnosed at stereotactic core-needle biopsy: surgical biopsy findings. Eur Radiol 16(8): 1803–1810
Mac Grogan G, Tavassoli FA (2003) Central atypical papillomas of the breast: a clinicopathological study of 119 cases. Virchows Arch 443: 609–617
Mahoney MC, Robinson-Smith TM, Shaughnessy EA (2006) Lobular neoplasia at 11-gauge vacuum-assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up. AJR Am J Roentgenol 187: 949–954
Mann RM, Kuhl CK, Kinkel K, Boetes C (2008) Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol 18(7): 1307–1318
Martino S, Cauley JA, Barrett-Connor E, et al. (2004) Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene. J Natl Cancer Inst 96: 1751–1761
McCormack VA, dos Santos Silva I (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15(6): 1159–1169
Moinfar F, Man YG, Bratthauer GL, et al. (2000) Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type (“clinging ductal carcinoma in situ”): a simulator of normal mammary epithelium. Cancer 88: 2072–2081
Mokbel K, Price RK, Carpenter R (1999) Radial scars and breast cancer. N Engl J Med 341: 210
Mokbel K, Price RK, Mostafa A, et al. (1999) Radial scar and carcinoma of the breast: microscopic findings in 32 cases. Breast 8: 339–342
Morris EA, Liberman L, Ballon DJ, et al. (2003) MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol 181(3): 619–626
Mouridsen HT, Rose C, Overgaard M, et al. (1988) Adjuvant treatment of postmenopausal patients with high-risk primary breast cancer. Results from the Danish adjuvant trials DBCG 77 C and DBCG 82 C. Acta Oncol 27: 699–705
MRC (1987) Adjuvant tamoxifen in the management of operable breast cancer: the Scottish Trial. Report from the Breast Cancer Trials Committee, Scottish Cancer Trials Office (MRC), Edinburgh. Lancet 2: 171–175
National Comprehensive Cancer Network (2009) National clinical practice guidelines in oncology: breast cancer screening and diagnosis. Version 1.2010. Published mars 11, www.nccn.org
Ohuchi N, Abe R, Takahashi T, Tezuka F (1984) Origin and extension of intraductal papillomas of the breast: a three-dimensional reconstruction study. Breast Cancer Res Treat 4(2): 117–128
O’Malley FP, Mohsin SK, Badve S, et al. (2006) Interobserver reproducibility in the diagnosis of flat epithelial atypia of the breast. Mod Pathol 19: 172–179
Page DL, Dupont WD (1990) Anatomic markers of human premalignancy and risk of breast cancer. Cancer 66: 1326–1335
Page DL, Dupont WD, Jensen RA (1996) Papillary apocrine change of the breast: associations with atypical hyperplasia and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 5: 29–32
Page DL, Dupont WD, Rogers LW, Rados MS (1985) Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 55: 2698–2708
Page DL, Kidd Jr TE, Dupont WD, et al. (1991) Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 22: 1232–1239
Page DL, Salhany KE, Jensen RA, Dupont WD (1996) Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma. Cancer 78(2): 258–266
Page DL, Schuyler PA, Dupont WD, et al. (2003) Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet 361: 125–129
Patterson JA, Scott M, Anderson N, Kirk SJ (2004) Radial scar, complex sclerosing lesion and risk of breast cancer. Analysis of 175 cases in Northern Ireland. Eur J Surg Oncol 30(10): 1065–1068
Pauw AD, Stoppa-Lyonnet D, Andrieu N (2009) Asselain estimation of individual breast cancer risk: relevance and limits of risk estimation models B. Bull Cancer 96(10): 979–988 [French]
Pisano ED, Hendrick RE, Yaffe MJ, et al. (2008) DMIST Investigators Group. Diagnostic accuracy of digital vs film mammography: exploratory analysis of selected population subgroups in DMIST. Radiology 246: 376–383
Plantade R, Hammou JC, Fighiera M, et al. (2004) Underestimation of breast carcinoma with 11-gauge stereotactically guided directional vacuum-assisted biopsy. J Radiol 85: 391–401.
Poller DN, Snead DR, Roberts EC, et al. (1993) Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein. Br J Cancer 68: 156–161
Port ER, Park A, Borgen PI, et al. (2007) Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia. Ann Surg Oncol 14(3): 1051–1057
Powles TJ, Ashley S, Tidy A, et al. (2007) Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial. J Natl Cancer Inst 99: 283–290
Powles TJ, Jones AL, Ashley SE, et al. (1994) The Royal Marsden Hospital pilot tamoxifen chemoprevention trial. Breast Cancer Res Treat 31: 73–82
Rao A, Parker S, Ratzer E, et al. (2002) Atypical ductal hyperplasia of the breast diagnosed by 11-gauge directional vacuum-assisted biopsy. Am J Surg 184: 534–537 [537 discussion]
Recommandations professionnelles (2009) Cancer du sein in situ. Octobre; www.e-cancer.fr
Renshaw AA, Derhagopian RP, Martinez P, Gould EW (2006) Lobular neoplasia in breast core needle biopsy specimens is associated with a low-risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision. Am J Clin Pathol 126: 310–313
Reynolds HE, Poon CM, Goulet RJ (1998) Biopsy of breast microcalcifications using an 11-gauge directional vacuum-assisted device. AJR Am J Roentgenol 171: 611–613
Rutqvist LE, Cedermark B, Glas U, et al. (1991) Contralateral primary tumors in breast cancer patients in a randomized trial of adjuvant tamoxifen therapy. J Natl Cancer Inst 83: 1299–1306
Sanders ME, Page DL, Simpson JF, et al. (2006) Interdependence of radial scar and proliferative disease with respect to invasive breast carcinoma risk in patients with benign breast biopsies. Cancer 106: 1453–1461
Saslow D, Boetes C, Burke W, et al. (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57(2): 75–89 [Erratum in: CA Cancer J Clin 2007 May–Jun; 57(3): 185]
Schnitt SJ (2003) The diagnosis and management of pre-invasive breast disease: flat epithelial atypia-classification, pathologic features and clinical significance. Breast Cancer Res 5: 263–268
Schnitt SJ, Vincent-Salomon A (2003) Columnar cell lesions of the breast. Adv Anat Pathol 10: 113–124
Shaaban AM, Sloane JP, West CR, et al. (2002) Histopathologic types of benign breast lesions and the risk of breast cancer: case-control study. Am J Surg Pathol 26: 421–430
Simpson PT, Gale T, Reis-Filho JS, et al. (2005) Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis. Am J Surg Pathol 29:734–746
Sneige N, Lim SC, Whitman GJ, et al. (2003) Atypical ductal hyperplasia diagnosis by directional vacuum-assisted stereotactic biopsy of breast microcalcifications. Considerations for surgical excision. Am J Clin Pathol 119: 248–253
Sneige N, Wang J, Baker BA, et al. (2002) Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases. Mod Pathol 15: 1044–1050
Sohn V, Arthurs Z, Herbert G, et al. (2007) Atypical ductal hyperplasia: improved accuracy with the 11-gauge vacuum-assisted vs the 14-gauge core biopsy needle. Ann Surg Oncol 14: 2497–2501
Taffurelli M, Santini D, Martinelli G, et al. (1991) Juvenile papillomatosis of the breast. A multidisciplinary study. Pathol Annu 26(Pt 1): 25–35
Tavassoli F, Millis R, Boecker W, Lakhani S (2003) World Health Organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs, 60–76
Tavassoli FA (2000) Ductal intraepithelial neoplasia (IDH, AIDH and DCIS). Breast Cancer 7: 315–320
Tavassoli FA (2001) Ductal intraepithelial neoplasia of the breast. Virchows Arch 438: 221–227
Tsao AS, Kim ES, Hong WK (2004) Chemoprevention of cancer. CA Cancer J Clin 54: 150–180
Vachon CM, van Gils CH, Sellers TA, et al. (2007) Mammographic density, breast cancer risk and risk prediction. Breast Cancer Res 9(6): 217 [Review]
Van de Vijver MJ, Peterse H (2003) The diagnosis and management of pre-invasive breast disease: pathological diagnosis-problems with existing classifications. Breast Cancer Res 5: 269
Veronesi U, Maisonneuve P, Rotmensz N, et al. (2007) Tamoxifen for the prevention of breast cancer: late results of the Italian randomized tamoxifen prevention trial among women with hysterectomy. J Natl Cancer Inst 99: 727–737
Veronesi U, Maisonneuve P, Sacchini V, et al. (2002) Tamoxifen for breast cancer among hysterectomised women. Lancet 359: 1122–1124
Vogel VG (2004) Atypia in the assessment of breast cancer risk: implications for management. Diagn Cytopathol 30: 151–157
Vogel VG, Costantino JP, Wickerham DL, et al. (2006) Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 295: 2727–2741
Wang J, Costantino JP, Tan-Chiu E, et al. (2004) Lower-category benign breast disease and the risk of invasive breast cancer. J Natl Cancer Inst 96: 616–620
Warner E, Hill K, Causer P, et al. (2011) Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging. J Clin Oncol [in press]
Wattenberg LW (1985) Chemoprevention of cancer. Cancer Res 45: 1–8
Webb PM, Byrne C, Schnitt SJ, et al. (2002) Family history of breast cancer, age and benign breast disease. Int J Cancer 100: 375–378
Winchester DJ, Bernstein JR, Jeske JM, et al. (2003) Upstaging of atypical ductal hyperplasia after vacuum-assisted 11-gauge stereotactic core needle biopsy. Arch Surg 138: 619–622 [622–3 discussion]
Yeh IT, Dimitrov D, Otto P, et al. (2003) Pathologic review of atypical hyperplasia identified by image guided breast needle core biopsy. Correlation with excision specimen. Arch Pathol Lab Med 127: 49–54
Références électroniques
[A] BOADICEA http://www.srl.cam.ac.uk/genepi/boadicea/boadicea_home.html
[B] BRCAPRO http://astor.som.jhmi.edu/BayesMendel/brcapro.html
[C] INCa http://www.e-cancer.fr
[D] NCCN update 2010 (http://www.nccn.org)
[E] NICE clinical guideline 41 update october 2006 (http://www.nice.org.uk/guidance)
About this article
Cite this article
Cohen, M., Jacquemier, J., Maestro, C. et al. Femmes à risque. Oncologie 13, 618–644 (2011). https://doi.org/10.1007/s10269-011-2074-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10269-011-2074-4